Filtered By:
Condition: Asthma

This page shows you your search results in order of relevance. This is page number 16.

Order by Relevance | Date

Total 773 results found since Jan 2013.

Changes in EMS utilization in the state of Maryland during the first 6 months of the COVID-19 pandemic
CONCLUSION: In the state of Maryland, overall call volumes decreased, but the proportion of EMS patients with time-sensitive illnesses increased during the COVID-19 pandemic.PMID:35913182 | DOI:10.5055/ajdm.2022.0418
Source: American Journal of Disaster Medicine - August 1, 2022 Category: International Medicine & Public Health Authors: Gregory Jasani Teferra Alemayehu Timothy Chizmar Lucy Wilson Source Type: research

Cardiovascular safety of genetically proxied interleukin-5 inhibition: A mendelian randomization study
Respir Investig. 2023 Jan 20;61(2):149-152. doi: 10.1016/j.resinv.2022.12.004. Online ahead of print.ABSTRACTInterleukin-5 (IL-5) inhibitors have revolutionized the management of eosinophilic asthma. However, IL-5 is thought to play a protective role in atherosclerosis, and cardiovascular safety data for IL-5i are scarce. We used population-level data to examine the association between genetically proxied IL-5i and the risk of cardiovascular diseases. Genetic instruments for IL-5i were selected from a genome-wide association study of eosinophil count in 563,946 individuals. Genetic association data for coronary artery dise...
Source: Atherosclerosis - January 22, 2023 Category: Cardiology Authors: Philip Alton David M Hughes Sizheng Steven Zhao Source Type: research

Trends in the Prevalence of Chronic Non-Communicable Diseases and Multimorbidity across Socioeconomic Gradients in Rural Southwest China
ConclusionsThe prevalence of NCDs multimorbidity increased substantially across all socioeconomic gradients in rural southwest China. Future interventions to further manage NCDs and their multimorbidity must be tailored to address socioeconomic factors.
Source: The Journal of Nutrition, Health and Aging - June 5, 2023 Category: Nutrition Source Type: research

Can ‘toxic’ bilirubin treat a variety of illnesses?
Generations of medical and biology students have been instilled with a dim view of bilirubin. Spawned when the body trashes old red blood cells, the molecule is harmful refuse and a sign of illness. High blood levels cause jaundice, which turns the eyes and skin yellow and can signal liver trouble. Newborns can’t process the compound, and although high levels normally subside, a persistent surplus can cause brain damage. Yet later this year up to 40 healthy Australian volunteers may begin receiving infusions of the supposedly good-for-nothing molecule. They will be participating in a phase 1 safety trial, sponsored ...
Source: ScienceNOW - June 8, 2023 Category: Science Source Type: news